Ys Biopharma Co Ltd. (YS)
Market Open
24 May, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 02
+0.09
+9.6774%
$
192.09M Market Cap
- P/E Ratio
- Div Yield
102,955 Volume
- Eps
$ 0.93
Previous Close Want to track YS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ys Biopharma Co Ltd. (YS) Statistics
Valuation metrics
Market Cap 192.09M
Enterprise value 405.83M
Trailing P/E (ttm) -0.51
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.03
Price/Book (mrq) 0.1
Enterprise Value/Revenue 0.66
Enterprise Value/EBITDA -8.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1K
Average volume (90 days) 8.95K
Price summary
52-Week low 0.35
52-Week high 1.78
Beta -
50-Day moving average 0.06
200-Day moving average 0.45
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 1 Oct 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.16%
Operating margin -0.14%
Operational effectiveness
Return on assets -0.07%
Return on equity -0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 5.75
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.26
Total debt (mrq) -
Total Debt/Equity (mrq) 0.83
Current ratio (mrq) 1.02%
Book value per share (mrq) 4.67
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
